MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance
Open Access
- 3 January 2014
- journal article
- Published by Springer Nature in Molecular Cancer
- Vol. 13 (1) , 1
Abstract
Background: Development of resistance to androgen deprivation therapy (ADT) is a major obstacle for the management of advanced prostate cancer. Therapies with androgen receptor (AR) antagonists and androgen withdrawal initially regress tumors but development of compensatory mechanisms including AR bypass signaling leads to re-growth of tumors. MicroRNAs (miRNAs) are small regulatory RNAs that are involved in maintenance of cell homeostasis but are often altered in tumor cells.Results: In this study, we determined the association of genome wide miRNA expression (1113 unique miRNAs) with development of resistance to ADT. We used androgen sensitive prostate cancer cells that progressed to ADT and AR antagonist Casodex (CDX) resistance upon androgen withdrawal and treatment with CDX. Validation of expression of a subset of 100 miRNAs led to identification of 43 miRNAs that are significantly altered during progression of cells to treatment resistance. We also show a correlation of altered expression of 10 proteins targeted by some of these miRNAs in these cells.Conclusions: We conclude that dynamic alterations in miRNA expression occur early on during androgen deprivation therapy, and androgen receptor blockade. The cumulative effect of these altered miRNA expression profiles is the temporal modulation of multiple signaling pathways promoting survival and acquisition of resistance. These early events are driving the transition to castration resistance and cannot be studied in already developed CRPC cell lines or tissues. Furthermore our results can be used a prognostic marker of cancers with a potential to be resistant to ADT.Keywords
This publication has 145 references indexed in Scilit:
- Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1BCancer Medicine, 2012
- Epidermal growth factor increases LRF/Pokemon expression in human prostate cancer cellsExperimental and Molecular Pathology, 2011
- Prostate Epithelial Pten/TP53 Loss Leads to Transformation of Multipotential Progenitors and Epithelial to Mesenchymal TransitionThe American Journal of Pathology, 2011
- CAMP (C13orf8, ZNF828) is a novel regulator of kinetochore–microtubule attachmentThe EMBO Journal, 2010
- MicroRNA-143 as a Tumor Suppressor for Bladder CancerJournal of Urology, 2009
- Suppression of cell growth and invasion by miR-205 in breast cancerCell Research, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- A Mammalian microRNA Expression Atlas Based on Small RNA Library SequencingCell, 2007
- Diverse functions of RNase L and implications in pathologyBiochimie, 2007
- c-Myc-regulated microRNAs modulate E2F1 expressionNature, 2005